908 Devices Inc.

Overview

908 Devices develops and sells purpose-built handheld chemical analysis devices for rapid, point-of-need identification of unknown materials. The platform combines mass spectrometry with optical spectroscopy, analytics, and machine learning to produce fast, actionable results for health, safety, border control, and defense applications.

Core technology and platform

• Mass spectrometry
  • Proprietary microscale ion trap and vacuum system designed for handheld mass spectrometers.
  • Miniaturized Mass Spec components with efficient vacuum and low power requirements (vacuum system under one pound; total device power under 20 watts; up to 100x lower power consumption versus some competitors).
• Optical spectroscopy
  • Vibrational spectroscopy capabilities (FTIR and Raman) added through the April 2024 acquisition of RedWave Technology (CAM2 Technologies).
• Analytics and machine learning
  • Embedded autonomous control and machine-learning–based interpretation that provide identifications and quantities rather than raw data alone.
• Target users and applications
  • Point-of-need analysis optimized for front-line operators: law enforcement, fire and HazMat teams, military, customs and border protection, and other first responders.

Products

• MX908
  • Handheld mass spectrometer for rapid analysis of solids, liquids, vapors, and aerosols.
  • Detects 160+ named hazardous materials, including fentanyl and derivatives, explosives, and hazardous chemicals.
  • Startup under one minute; analysis from seconds to minutes; ruggedized for outdoor use. Thousands of operators trained.
• XplorIR
  • Handheld FTIR device identifying 5,600+ gases/vapors and quantifying ~5,000 airborne chemicals in under a minute.
  • Continuous monitoring cycle of roughly every 4 seconds.
  • Headless version (InterceptIR) available for robotic platforms.
• ThreatID
  • FTIR-based device with a library covering 28,000+ hazards; rugged interfaces and guided prompts for simple operation.
• ProtectIR
  • Handheld FTIR for identification of 23,000+ bulk chemical hazards; field-ready design.
• VipIR
  • 3-in-1 handheld analyzer combining FTIR, Raman, and Smart Spectral Processing (SSP).
  • Library of 39,000+ spectra, multiple sampling modes, and data sharing via a Team Leader app.
• Consumables and services
  • Standard and extended hardware warranties, training, 24/7/365 Reachback technical support, software and spectral library updates.
  • Single-use swabs for MX908 analysis; some consumables are single-source while others are non-proprietary.

Company history and growth

• Installed base and sales
  • More than 3,700 handheld devices sold to over 700 customers globally since 2014.
  • MX908: over 3,100 units sold across the U.S. and five continents; more than 14,000 operators trained on MX908.
• Corporate actions
  • Acquired Trace Analytics GmbH in 2022.
  • Acquired RedWave Technology (CAM2 Technologies) in April 2024 for FTIR and Raman capabilities.
• International expansion
  • Growth through expanded direct sales and a network of more than 64 channel partners; targeting Europe, Middle East, Asia-Pacific, Australia, and South America.

Customers and channels

• Primary customers: government agencies and, to a lesser extent, life sciences organizations.
• Primary users: law enforcement, military, civilian first responders, and customs/border protection personnel.
• Sales model: mix of direct field sales and channel partners; many government sales proceed through tenders and extended procurement cycles.

Manufacturing and operations

• In-house manufacturing in Danbury, Connecticut for mass spec and optical devices; metal and plastic components sourced from contractors.
• Additional machining and assembly support in Stamford, CT and Georgetown, MA.
• ISO 9001:2015 certified manufacturing.
• Capacity
  • Danbury facility capacity approximates 1,000 mass spec devices and 1,000 optical devices per year; with existing staffing, combined capacity up to ~5,000 devices annually.
  • Ability to qualify multiple contract manufacturers if demand exceeds internal capacity.
• Primary facilities (as of 12/31/2025)
  • Burlington, MA — corporate headquarters and R&D (12,800 sq ft)
  • Danbury, CT — R&D, assembly, manufacturing (38,200 sq ft)
  • Georgetown, MA — assembly, manufacturing (3,500 sq ft)
  • Stamford, CT — assembly, manufacturing (11,500 sq ft)

People and human capital

• Workforce (as of 12/31/2025): 172 full-time employees
  • Sales / sales support / marketing: 35
  • Engineering and R&D: 43 (about 49% hold advanced degrees)
  • Manufacturing / operations / service: 62
  • General and administrative: 32
• Leadership includes company co-founders; emphasis on experienced leadership and technical talent.

Intellectual property

• Patents (as of 12/31/2025)
  • Owned: ~14 U.S. patents; 2 pending U.S. applications; ~10 foreign patents; 5 foreign pending applications.
  • In-licensed: ~30 U.S. patents; 1 pending U.S. application; ~18 foreign patents; 1 pending foreign application.
  • UNC license: exclusive worldwide license for a microfabricated ionization source and ionizer chip, with ongoing royalties and development diligence; sublicense to Repligen executed in March 2025; UNC license term extends through the life of the licensed patents (expected at least through 2037).
• Patent coverage
  • Patents address miniature mass spectrometry technology, ionization and microfabrication methods, high-pressure operation, sample injection, integrated microchips, and related methods.
  • Patent terms and expirations vary; maintenance and foreign filings are required.
• Trademarks and domains
  • U.S. and international trademarks for 908 Devices, MX908, VipIR, XplorIR, and the company logo, along with multiple domain registrations.

Licenses and collaborations

• UNC Agreement (initial June 2012; amended 2013–2015)
  • Exclusive worldwide license to UNC patents covering microfabricated mass spectrometry technology, with royalty obligations and minimum annual royalties; company bears patent prosecution and maintenance costs as required.
• Repligen sublicense (March 2025)
  • Sublicense under the UNC Agreement with royalty flows to UNC.
• Ongoing licensing
  • The company relies on inbound licenses for key technologies; some licenses are non-exclusive.

Regulatory and security

• Export controls and sanctions
  • Products are subject to EAR/ITAR determinations and OFAC considerations; compliance obligations and potential penalties apply for violations.
• Data privacy and cybersecurity
  • Company-wide cybersecurity risk management and vendor risk processes; compliance efforts cover PCI DSS, GDPR/UK GDPR, and other regional privacy laws.
• Government contracting compliance
  • Government contracts are subject to audits, cost accounting rules, and contractual oversight, with associated compliance obligations.

Financial highlights

• Revenue and profitability
  • The company has a history of net losses and may not achieve profitability.
  • 2025 revenue is reported as largely from handheld products.
• Growth and capital
  • Continued investments in R&D and sales; potential need for additional capital.
  • Existing credit facilities include a revolving line of credit extended through 2026 with covenants and potential default events.
• Sales concentration and cycles
  • A significant portion of historical revenue is tied to U.S. government programs; procurement cycles can be long and dependent on budgetary and political factors.

Key takeaways

• 908 Devices offers a suite of handheld, field-ready chemical analyzers that combine miniature mass spectrometry with complementary FTIR and Raman spectroscopy.
• The company has an established installed base, trained operator network, and a product portfolio expanded through strategic acquisitions.
• Intellectual property and regulatory compliance are central to the business model, and operations include in-house manufacturing with the ability to scale via contract manufacturers if needed.